KS119W

KS119W is a research-stage small molecule and structural analog of KS119, a hypoxia-activated prodrug (HAP) belonging to the sulfonylhydrazine class. Like its parent compound, KS119W is designed to remain inactive in well-oxygenated tissues but undergo enzymatic reduction in the hypoxic microenvironment characteristic of solid tumors. This reduction triggers the release of a potent DNA-alkylating cytotoxin, specifically a 1,2-bis(methylsulfonyl)hydrazine derivative, which induces cell death by damaging genomic DNA. In scientific literature, KS119W is frequently utilized as a reference standard or internal control in HPLC-based analytical protocols to study the pharmacokinetics, metabolic stability, and activation kinetics of the KS119 series of anticancer agents.